Whole blood GRHL2 expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancer.
Kwan EM, Fettke H, Crumbaker M, Docanto MM, To SQ, Bukczynska P, Mant A, Ng N, Foroughi S, Graham LK, Haynes AM, Azer S, Lim LE, Segelov E, Mahon K, Davis ID, Parente P, Pezaro C, Todenhöfer T, Sathianathen N, Hauser C, Horvath LG, Joshua AM, Azad AA.
Kwan EM, et al. Among authors: ng n.
Transl Androl Urol. 2021 Apr;10(4):1688-1699. doi: 10.21037/tau-20-1444.
Transl Androl Urol. 2021.
PMID: 33968657
Free PMC article.